Literature DB >> 27578952

Rheumatoid arthritis associated interstitial lung disease: 1 year is too much to exclude methotrexate-induced pulmonary involvement.

Ashok Kuwal1, Naveen Dutt1, Nishant Chauhan1.   

Abstract

Entities:  

Year:  2016        PMID: 27578952      PMCID: PMC4948247          DOI: 10.4103/0970-2113.184950

Source DB:  PubMed          Journal:  Lung India        ISSN: 0970-2113


× No keyword cloud information.
Sir, We read the article, “Pulmonary involvement in rheumatoid arthritis: A cross-sectional study in Iran” by Zayeni et al.[1] with great interest. The authors have evaluated 44 patients of rheumatoid arthritis with pulmonary function testing (PFT), chest X-ray, high-resolution computed tomography (HRCT) of the lungs, and disease activity score 28. The authors have excluded the patients with history of smoking and use of drugs such as gold, penicillamine, sulfasalazine, and methotrexate for more than 1 year. Rheumatoid arthritis associated interstitial lung disease (RA-ILD) is more commonly found in male, history of smoking, and high titers of rheumatoid factor and with duration of the disease.[2] In the present study, the male are under-represented (9 patients, 20.45%) and smokers have been excluded totally. Thus, the study has significant selection bias. Studies suggest that methotrexate-induced ILD is most frequently occurs after 4–6 months after initiation of therapy.[34] The authors tried to exclude methotrexate-induced ILD by exclusion of patients taking methotrexate for more than 1 year. While this did not exclude patients having methotrexate-induced ILD, it might have excluded patients having long duration of RA which is linked with development of RA-ILD. Second, the authors mentioned HRCT findings as nodules, fibrosis, cyst, bronchiectasis, air trapping, and bronchiolectasia. However, RA-ILD is classically divided into usual interstitial pneumonia (UIP), nonspecific interstitial pneumonia, organizing pneumonia, lymphocytic interstitial pneumonia (LIP), bronchiolitis, etc. Hence, the present study lacks these specific patterns of ILD which are recognized worldwide. According to available literature, UIP is the most common form of ILD in RA.[2] Third, the authors have stated that “air trapping” was the most common finding in patient's PFT, and there is no mention of PFT variables in the present study. Instead of simply summarizing these PFT findings, the authors could have mentioned the PFT variables which would be more helpful for quantification and severity grading of lung function.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  4 in total

1.  Variation of immunological response in methotrexate-induced pneumonitis.

Authors:  B Chikura; N Sathi; S Lane; J K Dawson
Journal:  Rheumatology (Oxford)       Date:  2008-09-23       Impact factor: 7.580

Review 2.  Methotrexate-related pulmonary complications in rheumatoid arthritis.

Authors:  P Barrera; R F Laan; P L van Riel; P N Dekhuijzen; A M Boerbooms; L B van de Putte
Journal:  Ann Rheum Dis       Date:  1994-07       Impact factor: 19.103

Review 3.  Rheumatoid arthritis-associated interstitial lung disease: the relevance of histopathologic and radiographic pattern.

Authors:  Eunice J Kim; Harold R Collard; Talmadge E King
Journal:  Chest       Date:  2009-11       Impact factor: 9.410

4.  Pulmonary involvement in rheumatoid arthritis: A cross-sectional study in Iran.

Authors:  Habib Zayeni; Asghar Haji-Abbasi; Seyed Ali Alavi Foumani; Mehdi Tohidi; Irandokht Shenavar Masooleh; Banafsheh Ghavidel Parsa; Mehrdad Aghaei; Amir Hassankhani; Pooneh Ghavidel Parsa; Alireza Amir Maafi
Journal:  Lung India       Date:  2016 Jan-Feb
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.